Similar articles

• EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

  Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Gordon C, Boumpas DT; Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Bertsias G, et al. Ann Rheum Dis. 2008 Feb;67(2):195-205. doi: 10.1136/ard.2007.070367. Epub 2007 May 15. Ann Rheum Dis. 2008. PMID: 17504841
• Pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Practical messages from the EULAR guidelines.

  Vagelli R, Tani C, Mosca M. Vagelli R, et al. Pol Arch Intern Med. 2017 Jan 25;127(2):115-121. doi: 10.20452/pamw.3906. Epub 2017 Jan 25. Pol Arch Intern Med. 2017. PMID: 28120818 Review.
• Systemic lupus erythematosus in pregnancy.

  Duerbeck NB, Coney PJ. Duerbeck NB, et al. Compr Ther. 1998 Mar;24(3):123-8. Compr Ther. 1998. PMID: 9559246 Review.
• Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus.

  Somerset DA, Raine-Fenning N, Gordon C, Weaver JB, Kilby MD. Somerset DA, et al. Eur J Obstet Gynecol Reprod Biol. 1998 Aug;79(2):227-9. doi: 10.1016/s0301-2115(98)00070-0. Eur J Obstet Gynecol Reprod Biol. 1998. PMID: 9720848 No abstract available.
• A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus.

  Lazzaroni MG, Dall'Ara F, Fredi M, Nalli C, Reggia R, Lojacono A, Ramazzotto F, Zatti S, Andreoli L, Tincani A. Lazzaroni MG, et al. J Autoimmun. 2016 Nov;74:106-117. doi: 10.1016/j.jaut.2016.06.016. Epub 2016 Jul 2. J Autoimmun. 2016. PMID: 27377453 Review.